UC Irvine in clinical trial to test antiviral treatment for COVID-19

The UC Irvine Medical Center announced Monday that it is participating in a clinical trial to test whether the antiviral drug remdesivir can be used to treat COVID-19, the disease caused by the novel coronavirus. … Dr. Alpesh Amin, executive director of UCI’s Hospitalist Program, said the medication is part of a family of nucleotide analogues and it “attacks the genetic code of the virus.” … “Given the uniqueness of the pandemic situation that we have, there is a possibility that if the results are very good, some quick decisions could be made,” he said.